These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1759 related items for PubMed ID: 27343380

  • 1. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.
    Eur J Pharmacol; 2016 Oct 05; 788():200-209. PubMed ID: 27343380
    [Abstract] [Full Text] [Related]

  • 2. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M.
    J Hepatol; 2014 May 05; 60(5):1017-25. PubMed ID: 24362075
    [Abstract] [Full Text] [Related]

  • 3. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y.
    Mol Metab; 2017 Jan 05; 6(1):138-147. PubMed ID: 28123944
    [Abstract] [Full Text] [Related]

  • 4. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM, Paraíso AF, de Oliveira MV, Martins AM, Neto JF, Guimarães AL, de Paula AM, Qureshi M, Santos SH.
    Nutrition; 2014 Jan 05; 30(7-8):915-9. PubMed ID: 24985011
    [Abstract] [Full Text] [Related]

  • 5. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M, Gavito AL, Pavón FJ, Bautista D, Serrano A, Suarez J, Arrabal S, Decara J, Romero-Cuevas M, Rodríguez de Fonseca F, Baixeras E.
    Dis Model Mech; 2015 Jul 01; 8(7):721-31. PubMed ID: 26035386
    [Abstract] [Full Text] [Related]

  • 6. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH, Chen JW, Kong ZL, Wu JC, Ho CT, Lai CS.
    J Agric Food Chem; 2018 Dec 05; 66(48):12685-12695. PubMed ID: 30415544
    [Abstract] [Full Text] [Related]

  • 7. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS, Kim JH, Kim HJ, Chang KC, Park SW.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):113-24. PubMed ID: 25737164
    [Abstract] [Full Text] [Related]

  • 8. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 9. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 10. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ.
    World J Gastroenterol; 2017 Jun 07; 23(21):3805-3814. PubMed ID: 28638220
    [Abstract] [Full Text] [Related]

  • 11. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS, Park CM, Kim HA, Kim HJ, Park JW, Park JC, Rhyu DY.
    J Ethnopharmacol; 2024 Feb 10; 320():117395. PubMed ID: 37952731
    [Abstract] [Full Text] [Related]

  • 12. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

  • 13. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y, Choi SI, Hong E, Kim GH.
    J Food Sci; 2020 Jul 01; 85(7):2216-2226. PubMed ID: 32579753
    [Abstract] [Full Text] [Related]

  • 14. Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver.
    Salomone F, Barbagallo I, Godos J, Lembo V, Currenti W, Cinà D, Avola R, D'Orazio N, Morisco F, Galvano F, Li Volti G.
    Nutrients; 2017 Sep 30; 9(10):. PubMed ID: 28973994
    [Abstract] [Full Text] [Related]

  • 15. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK, Dai W, Zheng YW, Zhao SP.
    Mol Med; 2019 Jun 13; 25(1):26. PubMed ID: 31195981
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, Zhang J, Wang T, Xin W, Yu C, Guan Q, Zhou X, Gao L, Xu C, Zhao J.
    J Hepatol; 2014 Dec 13; 61(6):1358-64. PubMed ID: 25016220
    [Abstract] [Full Text] [Related]

  • 17. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
    Ideta T, Shirakami Y, Miyazaki T, Kochi T, Sakai H, Moriwaki H, Shimizu M.
    Int J Mol Sci; 2015 Dec 08; 16(12):29207-18. PubMed ID: 26670228
    [Abstract] [Full Text] [Related]

  • 18. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
    Chen K, Chen X, Xue H, Zhang P, Fang W, Chen X, Ling W.
    Food Funct; 2019 Feb 20; 10(2):814-823. PubMed ID: 30675881
    [Abstract] [Full Text] [Related]

  • 19. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
    Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, Huang WC.
    Cells; 2019 May 11; 8(5):. PubMed ID: 31083505
    [Abstract] [Full Text] [Related]

  • 20. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling.
    Peng CH, Yang MY, Yang YS, Yu CC, Wang CJ.
    Am J Chin Med; 2017 May 11; 45(1):67-83. PubMed ID: 28161992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.